SCHEMBL755703

SCHEMBL755703

CC(C(=O)O)N(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
PGR P06401 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL755702 1.00 ALDH1A1 (0.43) ALDH1A1NPSR1LMNATP53SMN1; SMN2
Hydrochloric Acid SCHEMBL8226911 0.98 ALDH1A1 (0.42) ALDH1A1NPSR1LMNATP53SMN1; SMN2
Hydrochloric Acid SCHEMBL32662705 0.98 ALDH1A1 (0.42) ALDH1A1NPSR1LMNATP53SMN1; SMN2
Hydrochloric Acid SCHEMBL8226909 0.98 ALDH1A1 (0.42) ALDH1A1NPSR1LMNATP53SMN1; SMN2
SCHEMBL1997224 0.88 PTGS2 (0.52) ALDH1A1LMNASMN1; SMN2HTTADAMTS4
SCHEMBL8726244 0.88 PTGS2 (0.52) ALDH1A1LMNASMN1; SMN2HTTADAMTS4
SCHEMBL10351875 0.84 PTGS2 (0.43) ADAMTS4PTGS2
SCHEMBL7419927 0.83 ALDH1A1 (0.41) ALDH1A1NPSR1LMNATP53SMN1; SMN2
SCHEMBL8605929 0.83 ALDH1A1 (0.44) ALDH1A1LMNATP53SMN1; SMN2TSHR
SCHEMBL31370844 0.83 ALDH1A1 (0.44) ALDH1A1LMNATP53SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0561877-B1 COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION UNIV MELBOURNE (AU) 1999-06-16 EP claimed
US-5710012-A DETECTION OF CHOLESTEROL BY RELEASE OF HYDROGEN PEROXIDE ACTIMED LABORATORIES, INC. (US) 1998-01-20 US claimed
EP-0561877-A1 COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION THE UNIVERSITY OF MELBOURNE (AU) 1993-09-29 EP claimed
US-5153236-A Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images HITACHI CHEMICAL CO., LTD. (JP) 1992-10-06 US claimed
WO-1992010511-A1 COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION THE UNIVERSITY OF MELBOURNE (AU) 1992-06-25 WO claimed
US-20250296915-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2025-09-25 US disclosed
CN-120077329-A Photosensitive resin composition, photosensitive resin laminate, and method for forming resist pattern 旭化成株式会社 2025-05-30 CN disclosed
CN-118159908-A Photosensitive element and method for forming resist pattern 旭化成株式会社 2024-06-07 CN disclosed
WO-2024085254-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE RESIN MULTILAYER BODY, AND METHOD FOR FORMING RESIST PATTERN 旭化成株式会社 2024-04-25 WO disclosed
CN-117769414-A Lactoyl amino acids for the treatment of metabolic disorders 小利兰·斯坦福大学托管委员会 2024-03-26 CN disclosed
CN-117624307-A Process for preparing cyclic organic compounds 中外制药株式会社 2024-03-01 CN disclosed
WO-2023074325-A1 PHOTOSENSITIVE ELEMENT, AND METHOD FOR FORMING RESIST PATTERN 旭化成株式会社 2023-05-04 WO disclosed
US-5401783-A Adhesion-promoting agents incorporating polyvalent cations AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1995-03-28 US disclosed
US-5270351-A Adhesion-promoting agents incorporating polyvalent cations AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1993-12-14 US disclosed
EP-0561877-A1 COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION THE UNIVERSITY OF MELBOURNE (AU) 1993-09-29 EP disclosed
US-5153236-A Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images HITACHI CHEMICAL CO., LTD. (JP) 1992-10-06 US disclosed
WO-1992010511-A1 COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION THE UNIVERSITY OF MELBOURNE (AU) 1992-06-25 WO disclosed
EP-0295044-B1 PHOTOINITIATOR AND PHOTOPOLYMERIZABLE COMPOSITION USING THE SAME Hitachi Chemical Co., Ltd. (JP) 1992-04-22 EP disclosed
US-4987057-A HIGH SENSITIVITY TO VISIBLE LIGHT RAYS HITACHI CHEMICAL CO., LTD. (JP) 1991-01-22 US disclosed
EP-0295044-A2 Photoinitiator and photopolymerizable composition using the same Hitachi Chemical Co., Ltd. (JP) 1988-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250296915-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP ALDH1A1 4626/4885NPSR1 1710/4885LMNA 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.